TherapeuticsMD, Inc. (TXMD)

NASDAQ: TXMD · IEX Real-Time Price · USD
4.40
+0.25 (6.02%)
At close: Jun 2, 2023, 4:00 PM
4.11
-0.29 (-6.59%)
After-hours: Jun 2, 2023, 6:10 PM EDT

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2010
Revenue
69.962.5764.8749.6516.116.7819.3620.1415.038.78
Upgrade
Revenue Growth (YoY)
2619.12%-96.03%30.67%208.38%-4.04%-13.32%-3.90%34.05%71.23%129.85%
Upgrade
Cost of Revenue
1.41.415.986.342.742.644.194.513.671.96
Upgrade
Gross Profit
68.571.1748.943.3113.3614.1415.1715.6411.356.82
Upgrade
Selling, General & Admin
57.980.75194.01174.73115.9957.751.3528.7222.1219.01
Upgrade
Research & Development
0010.4319.7927.333.8553.9472.0443.2213.55
Upgrade
Other Operating Expenses
9.470000.290.210.130.060.050.06
Upgrade
Operating Expenses
67.3880.75204.44194.52143.5891.77105.42100.8365.432.62
Upgrade
Operating Income
1.19-79.58-155.54-151.21-130.22-77.63-90.25-85.19-54.04-25.81
Upgrade
Interest Expense / Income
0028.5817.384.6800001.17
Upgrade
Other Expense / Income
-110.8192.84-0.67.56-2.28-0.7-0.38-0.110.181.45
Upgrade
Pretax Income
112-172.42-183.52-176.15-132.62-76.93-89.88-85.08-54.22-28.42
Upgrade
Net Income
112-172.42-183.52-176.15-132.62-76.93-89.88-85.08-54.22-28.42
Upgrade
Shares Outstanding (Basic)
9865544333
Upgrade
Shares Outstanding (Diluted)
9865544333
Upgrade
Shares Change
17.66%44.39%11.89%9.48%9.49%4.81%13.23%15.66%17.37%39.22%
Upgrade
EPS (Basic)
12.41-21.66-33.50-36.00-29.50-18.50-23.00-24.50-18.00-11.00
Upgrade
EPS (Diluted)
11.96-21.66-33.50-36.00-29.50-18.50-23.00-24.50-18.00-11.00
Upgrade
Free Cash Flow Per Share
-0.45-17.93-28.96-34.13-23.78-18.54-17.73-22.87-15.21-8.16
Upgrade
Gross Margin
98.00%45.51%75.37%87.24%83.00%84.28%78.38%77.63%75.56%77.67%
Upgrade
Operating Margin
1.70%-3092.77%-239.77%-304.56%-808.85%-462.69%-466.27%-422.93%-359.65%-294.09%
Upgrade
Profit Margin
160.08%-6700.93%-282.90%-354.79%-823.74%-458.50%-464.32%-422.37%-360.82%-323.84%
Upgrade
Free Cash Flow Margin
-5.83%-5547.10%-246.14%-338.73%-664.80%-454.28%-359.25%-393.24%-303.15%-237.12%
Upgrade
EBITDA
113.19-171.68-150.88-157.37-127.65-76.71-89.74-85.01-54.16-27.2
Upgrade
EBITDA Margin
161.79%-6672.33%-232.57%-316.98%-792.86%-457.23%-463.63%-422.06%-360.47%-309.90%
Upgrade
Depreciation & Amortization
1.190.744.071.390.290.210.130.060.050.06
Upgrade
EBIT
112-172.42-154.94-158.76-127.94-76.93-89.88-85.08-54.22-27.25
Upgrade
EBIT Margin
160.08%-6700.93%-238.84%-319.78%-794.68%-458.50%-464.32%-422.37%-360.82%-310.56%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).